On the HCPLive multiple sclerosis page, resources on the topics of medical news and expert insight into MS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on primary progress and relapsing-remitting multiple sclerosis, and more.
December 9th 2022
As the treatment paradigm for neurologic diseases rapidly progresses, the need for more thorough biomarker tools to measure disease progression and severity has increased. In recent years, GFAP has emerged as a valuable candidate to add to the existing panel.
Sopranos Actress Diagnosed with Multiple Sclerosis
Jamie-Lynn Sigler, best known for her role as Tony Soprano’s daughter Meadow on “The Sopranos†from 1999 to 2007, revealed she was diagnosed with multiple sclerosis when she was just 20-years-old and has been living with the condition for nearly 15 years.
Promising Results for Rituximab Treatment for Acquired Hemophilia A
Treating acquired hemophilia A (AHA) with anti CD20 monoclonal antibody Rituximab is increasingly popular, according to a case study published in the Mediterranean Journal of Hematology and Infectious Diseases.
Living in Present Key in MS Patients' Outcomes
Positive thinking, including “concentrating on [a] hedonistic future†are signs a patient with remitting-relapsing multiple sclerosis (RRMS) has accepted his or her illness, a Polish study found. Acceptance is a treatment goal because it is associated with better compliance as well as a heightened sense of well-being, researchers said.
B Cell Depletion Therapy Appears Effective for Multiple Sclerosis Therapy
Researchers compared the B cells of patients with multiple sclerosis and healthy patients, specifically examining granulocyte macrophage colony stimulating factor (GM CSF), in order to determine their role in interactions between other immune cells within MS.
Psoriasis Treatment May Trigger Significant Adverse Effects
Study results suggest that a treatment for psoriasis and multiple sclerosis may induce a dangerous adverse effect, particularly in women. The finding is potentially important, because while treatment with fumaric acid esters has been around for more than 40 years, it is now being used more widely in the United States, Germany, and other areas.